Aristolochic Acid-DNA Adduct in Urothelial Carcinoma in Taiwan
This study is currently recruiting participants.
Verified February 2012 by National Taiwan University Hospital
Sponsor:
National Taiwan University Hospital
Information provided by (Responsible Party):
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT00867633
First received: March 22, 2009
Last updated: February 20, 2012
Last verified: February 2012
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | March 22, 2009 | ||||
| Last Updated Date | February 20, 2012 | ||||
| Start Date ICMJE | March 2009 | ||||
| Primary Completion Date | Not Provided | ||||
| Current Primary Outcome Measures ICMJE |
the incidence of aristolochic-acid DNA adduct in the samples [ Time Frame: one week ] [ Designated as safety issue: No ] | ||||
| Original Primary Outcome Measures ICMJE | Same as current | ||||
| Change History | Complete list of historical versions of study NCT00867633 on ClinicalTrials.gov Archive Site | ||||
| Current Secondary Outcome Measures ICMJE | Not Provided | ||||
| Original Secondary Outcome Measures ICMJE | Not Provided | ||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title ICMJE | Aristolochic Acid-DNA Adduct in Urothelial Carcinoma in Taiwan | ||||
| Official Title ICMJE | Observational Study of Aristolochic Acid-DNA Adduct in Urothelial Carcinoma in Taiwan | ||||
| Brief Summary | To study the association between aristolochic acid and urothelial carcinoma in Taiwan |
||||
| Detailed Description | Not Provided | ||||
| Study Type ICMJE | Observational | ||||
| Study Design ICMJE | Observational Model: Case Control Time Perspective: Cross-Sectional |
||||
| Target Follow-Up Duration | Not Provided | ||||
| Biospecimen | Retention: Samples With DNA Description: DNA extracted from the resected tissue samples |
||||
| Sampling Method | Probability Sample | ||||
| Study Population | The patients who received nephrectomies |
||||
| Condition ICMJE | Urothelial Carcinoma | ||||
| Intervention ICMJE | Not Provided | ||||
| Study Group/Cohort (s) |
|
||||
| Publications * | Not Provided | ||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Recruiting | ||||
| Estimated Enrollment ICMJE | 100 | ||||
| Estimated Completion Date | March 2012 | ||||
| Primary Completion Date | Not Provided | ||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
| Gender | Both | ||||
| Ages | Not Provided | ||||
| Accepts Healthy Volunteers | No | ||||
| Contacts ICMJE |
|
||||
| Location Countries ICMJE | Taiwan | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT00867633 | ||||
| Other Study ID Numbers ICMJE | 200804011R | ||||
| Has Data Monitoring Committee | No | ||||
| Responsible Party | National Taiwan University Hospital | ||||
| Study Sponsor ICMJE | National Taiwan University Hospital | ||||
| Collaborators ICMJE | Not Provided | ||||
| Investigators ICMJE | Not Provided | ||||
| Information Provided By | National Taiwan University Hospital | ||||
| Verification Date | February 2012 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||